FMP
Neovasc Inc.
NVCN
NASDAQ
Inactive Equity
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.
30.03 USD
0 (0%)
About
ceo
Mr. Fredericus A. Colen
sector
Healthcare
industry
Medical - Devices
website
https://www.neovasc.com
exchange
NASDAQ
Description
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.
CIK
0001399708
ISIN
CA64065J3047
CUSIP
64065J304
Address
13562 Maycrest Way
Phone
16042704344
Country
CA
Employee
49
IPO Date
May 23, 2001
Summary
CIK
0001399708
Exchange
NASDAQ
Industry
Medical - Devices
Sector
Healthcare
CUSIP
64065J304
ISIN
CA64065J3047
Country
CA
Price
30.03
Beta
2.01
Volume Avg.
25.78k
Market Cap
82.86M
Shares
-
52-Week
4.585-30.07
DCF
27.14
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-1.99
P/B
-
Website
https://www.neovasc.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest NVCN News
It looks like there's no news available.
